Emiliano Chisci

Dr. Emiliano Chisci


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2010 in Stroke
Verified
Journal Article
Closed access
CSCarlo Setacci
Carlo Setacci
ECEmiliano Chisci
Emiliano Chisci
FSFrancesco Setacci
Francesco Setacci
Francesca IacoponiFrancesca Iacoponi
Francesca Iacoponi
GDGianmarco de Donato
Gianmarco de Donato
ARAlessandro Rossi
Alessandro Rossi
Background and Purpose— Carotid artery stenting (CAS) still entails a considerable peri-interventional risk of serious neurological adverse events. The aim of this study was to generate a score to grade this risk for CAS in individual patients. Methods— This is a 9-year prospective study. Consecutive patients with ≥70% carotid artery stenosis were treated with a standardized CAS procedure. All patients included underwent independent neurological evaluation before and after the procedure and at 30 days. The rates of transient ischemic attack and minor, major, and fatal stroke were recorded. Stroke predictors were analyzed and a score system was generated using Arabic numerals for all variables to preoperatively grade the individual patient risk of stroke. Results— Two thousand one-hundred twenty-four successful CAS procedures were performed. The transient ischemic attack and minor, major, and fatal stroke rates at 30 days were, respectively, 2.72% (n=60), 1.55% (n=33), 1.18% (n=25), and 0.61% (n=13). Multiple regression analysis showed that the following significantly predicted the 30-day risk of treatment-related stroke: cardiac disease, symptomatic patient, diabetes, calcification or ulceration at the level of the lesion, native and ostial lesion, lesion length >15 mm, the need for predilatation, type III arch, bovine arch, arch calcification, procedure time >30 minutes, and the operator’s experience of 100 CAS procedures was the only protective factor against the development of stroke at 30 days (odds ratio, 0.81; confidence interval, 0.67–0.95). The Siena CAS score was developed from these variables and predicted the risk of CAS within the 3 categories of low risk (3%; CAS III), with a sensitivity of 0.82 and specificity of 0.79. Conclusions— The Siena CAS risk score seems to be a useful tool to help predict stroke after CAS but needs to be validated in independent cohorts at a variety of centers before it can be recommended for application, preferably in a randomized comparison with carotid endarterectomy.

1 December 2014 in AORTA
Verified
Journal Article
Open access
CSCarlo Setacci
Carlo Setacci
ECEmiliano Chisci
Emiliano Chisci
FSFrancesco Setacci
Francesco Setacci
LELeonardo Ercolini
Leonardo Ercolini
GDGianmarco de Donato
Gianmarco de Donato
SMStefano Michelagnoli
Stefano Michelagnoli
The prevalence of endograft infections (EI) after endovascular abdominal aortic aneurysm repair is below 1%. With the growing number of patients with aortic endografts and the aging population, the number of patients with EI might also increase. The diagnosis is based on an association of clinical symptoms, imaging, and microbial cultures. Angio-computed tomography is currently the gold-standard technique for diagnosis. Low-grade infection sometimes requires nuclear medicine imaging to make a correct diagnosis. There is no good evidence to guide management so far. In the case of active gastrointestinal bleeding, pseudoaneurysm, or extensive perigraft purulence involving adjacent organs, an invasive treatment should always be attempted. In the other cases (the majority), when there is not an immediate danger to the patient's life, a conservative management is started with a proper antimicrobial therapy. Any infectious cavity can be percutaneously drained. Management depends on the patient's condition and a tailored approach should always be offered. In the case of a patient who is young, has a good life expectancy, or in whom there is absence of significant comorbidities, a surgical attempt can be proposed. Surgical techniques favor, in terms of mortality, patency, and reinfection rate, the in situ reconstruction. Choice of technique relies on the center and the operator's experience. Long-term antibiotic therapy is always required in all cases, with close monitoring of the C-reactive protein.

1 April 2009 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
PDF file
ECEmiliano Chisci
Emiliano Chisci
TKThorarinn Kristmundsson
Thorarinn Kristmundsson
GDGianmarco de Donato
Gianmarco de Donato
TRTimothy Resch
Timothy Resch
FSFrancesco Setacci
Francesco Setacci
MMMartin Malina
Martin Malina
Purpose: To compare the outcome of endovascular aneurysm repair (EVAR) versus conventional open repair (OR) in patients with a short, angulated or otherwise challenging proximal neck. Methods: The definition of a challenging proximal neck was based on diameter (≥28 mm), length (≤15 mm), angulation (≥60°), shape (reverse tapered or bulging), and thrombus lining (>50%). Between January 2005 and December 2007, 187 consecutive patients (159 men; mean age 73 years, range 48–92) operated for asymptomatic abdominal aortic aneurysm (AAA) were identified as having challenging proximal neck morphology. Of these, 61 patients were treated with OR at center I (group A), 71 with standard EVAR (group B; 45 center I, 29 center II) and 52 with fenestrated EVAR (group C) at center II. Clinical examination and computed tomography were performed at 1 month and yearly thereafter. Results: There was no statistically significant difference between groups A, B, and C regarding primary technical success rate, 30-day mortality, or late AAA-related mortality. The mean length of follow-up was 19.5 months (range 0–40). Freedom from reintervention at 3 years was 91.8%, 79.7%, and 82.7% for groups A, B, and C, respectively (p=0.042). The only statistically significant difference between standard and fenestrated EVAR was a higher incidence of late sac expansion [9 (12.2%) versus 1 (1.9%), p=0.036] in the standard stent-graft group. Reinterventions were more frequent after EVAR (p=NS), but open reinterventions were more common after OR. Reinterventions after EVAR were related to the presence of an angulated (p=0.039) or short neck (p=0.024). Conclusion: The results of EVAR and OR were similar for AAAs with a challenging proximal neck. Endovascular reinterventions were more frequent after EVAR, particularly in patients with an angulated or short neck. Open reinterventions were more common after OR. More patients and long-term data are needed to confirm these findings.

1 August 2011 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
PDF file
ECEmiliano Chisci
Emiliano Chisci
FSFrancesco Setacci
Francesco Setacci
GDGianmarco de Donato
Gianmarco de Donato
CSCarlo Setacci
Carlo Setacci
Purpose To document a heretofore unreported complication of the contrast agent iodixanol during an endovascular procedure. Case Report A 76-year-old woman with a history of coronary artery disease was admitted to the emergency department for recurrent transient ischemic attacks. Before combined percutaneous transluminal coronary angioplasty and carotid artery stenting (CAS) using iodixanol, the patient suffered from concomitant unstable angina and recurrent transient ischemic attacks. The total amount of iodixanol used during the CAS procedure was 300 mL. Contrast-induced encephalopathy, which manifested as aphasia, stupor, and full hemiparesis immediately after the combined procedure, was diagnosed by urgent computed tomography. Treatment was based on anti-edema drugs, and the patient made a complete recovery within 48 hours, without any neurological sequelae. Conclusion Although previously reported in relation to other types of contrast media, contrast-induced encephalopathy has never been described as a complication of an endovascular procedure using iodixanol.

1 May 2012 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
ECEmiliano Chisci
Emiliano Chisci
APA. Perulli
A. Perulli
Francesca IacoponiFrancesca Iacoponi
Francesca Iacoponi
FSF. Setacci
F. Setacci
GDG. de Donato
G. de Donato
CSC. Setacci
C. Setacci

1 July 2018 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
ECEmiliano Chisci
Emiliano Chisci
LHLinda Harris
Linda Harris
AGAzzurra Guidotti
Azzurra Guidotti
APAngelica Pecchioli
Angelica Pecchioli
CPClara Pigozzi
Clara Pigozzi
SMStefano Michelagnoli
Stefano Michelagnoli